ZANI, Bianca Maria
 Distribuzione geografica
Continente #
NA - Nord America 474
AS - Asia 58
EU - Europa 57
Totale 589
Nazione #
US - Stati Uniti d'America 472
IN - India 26
SE - Svezia 22
CN - Cina 18
IT - Italia 16
SG - Singapore 14
IE - Irlanda 5
FI - Finlandia 3
UA - Ucraina 3
BE - Belgio 2
CA - Canada 2
DE - Germania 2
BG - Bulgaria 1
FR - Francia 1
GB - Regno Unito 1
RO - Romania 1
Totale 589
Città #
Fairfield 90
Ashburn 45
Woodbridge 43
Cambridge 37
Houston 37
Seattle 33
Wilmington 28
Chandler 22
Ann Arbor 18
Princeton 12
Lawrence 10
Plano 10
Boston 9
Beijing 7
Dearborn 6
Fremont 6
Andover 5
Dublin 5
Falls Church 5
Rome 5
San Diego 4
Milan 3
Millbury 3
Norwalk 3
Brussels 2
New York 2
San Paolo di Civitate 2
Shenzhen 2
Singapore 2
Ariccia 1
Baotou 1
Boardman 1
Bremen 1
Chicago 1
Chongqing 1
Des Moines 1
Guangzhou 1
Hefei 1
Helsinki 1
Huzhou 1
Jacksonville 1
Kunming 1
London 1
Los Angeles 1
Nanchang 1
Ottawa 1
Phoenix 1
Pune 1
San Mateo 1
Sofia 1
Toronto 1
Totale 478
Nome #
ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program 81
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population 74
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay 56
HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers 55
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy 54
Nerve growth factor regulation of cyclin D1 in PC12 cells through a p21 RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-κB 54
MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma 53
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis 52
p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and oncophenotype reversion in rhabdomyosarcoma cells 49
Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors 47
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma 25
Differentiation in culture of myogenic cells from adult mouse muscle 19
Totale 619
Categoria #
all - tutte 1.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 0 0 36
2019/2020190 23 4 2 7 19 23 24 35 18 13 19 3
2020/202156 12 3 4 4 0 9 2 0 8 7 6 1
2021/2022109 0 8 13 1 22 3 5 8 11 6 17 15
2022/2023107 24 18 9 14 12 8 4 4 11 1 1 1
2023/202440 2 8 1 3 12 5 0 0 0 9 0 0
Totale 619